JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD

Jiangsu Gdk Biological Technology Co., Ltd

688670

CNE100004NR4

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
16.91 ^CNY	+0.48%		+2.67%	-40.58%

Apr. 15	Jiangsu Gdk Biological Technology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Jiangsu Gdk Biological Technology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Jiangsu gdk Biotechnology Co., Ltd.(SHSE:688670) added to Shanghai Stock Exchange Composite Index

August 02, 2022 at 12:00 am EDT

Jiangsu gdk Biotechnology Co., Ltd Added to Shanghai Stock Exchange Composite Index.

Latest news about Jiangsu Gdk Biological Technology Co., Ltd

Jiangsu Gdk Biological Technology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 15	CI
Jiangsu Gdk Biological Technology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Jiangsu Gdk Biological Technology Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-02	CI
Jiangsu gdk Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-19	CI
Jiangsu gdk Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-24	CI
Jiangsu Gdk Biotechnology Forecasts Lower Profit in 2022 on COVID-19 Outbreaks	23-01-25	MT
Jiangsu gdk Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Jiangsu gdk Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-05	CI
Jiangsu gdk Biotechnology Co., Ltd.(SHSE:688670) added to Shanghai Stock Exchange A Share Index	22-08-02	CI
Jiangsu gdk Biotechnology Co., Ltd.(SHSE:688670) added to Shanghai Stock Exchange Composite Index	22-08-02	CI
Jiangsu gdk Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Jiangsu gdk Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-25	CI

Chart Jiangsu Gdk Biological Technology Co., Ltd

Duration

Period

Chart Jiangsu Gdk Biological Technology Co., Ltd

More charts

Jiangsu gdk Biotechnology Co Ltd is a biopharmaceutical company engaged in the research, development, production, and sales of human vaccines. The Companyâs main product is a tetravalent influenza virus split vaccine, which is mainly used to prevent influenza caused by two influenza A virus strains and two influenza B virus strains. The Company's research products also include a variety of human vaccines for the prevention of epidemic colds, rabies, chickenpox, shingles, and pneumonia. The Company distributes its service within the domestic market.

Sector

Pharmaceuticals

Calendar

2024-08-04 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

16.91

Average target price

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

	1st Jan change	Capi.
JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD	-40.58%	287M
CSL LIMITED	-4.59%	86.13B
SAMSUNG BIOLOGICS CO.,LTD.	+1.32%	39.82B
BIOGEN INC.	-19.27%	30.42B
UCB	+57.86%	25.23B
BIOMARIN PHARMACEUTICAL INC.	-16.09%	15.36B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.14%	11.95B
INCYTE CORPORATION	-17.69%	11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43.00%	11.51B
SWEDISH ORPHAN BIOVITRUM AB	+5.24%	8.71B

Biopharmaceuticals

Jiangsu Gdk Biological Technology Co., Ltd

Equities

688670

CNE100004NR4

Pharmaceuticals

Jiangsu gdk Biotechnology Co., Ltd.(SHSE:688670) added to Shanghai Stock Exchange Composite Index

Latest news about Jiangsu Gdk Biological Technology Co., Ltd

Chart Jiangsu Gdk Biological Technology Co., Ltd

Company Profile

Income Statement Evolution

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Biopharmaceuticals